Preview

Medical Genetics

Advanced search
Open Access Open Access  Restricted Access Subscription Access

Study of neurofibromatosis type 1 in the Republic of Bashkortostan – results and prospects

https://doi.org/10.25557/2073-7998.2025.08.77-79

Abstract

   Introduction. Neurofibromatosis type 1 (NF1) is one of the most common hereditary tumor syndromes caused by NF1 gene mutations. For differential diagnostics and reliable diagnosis of NF1, finding NF1 gene mutation is crucial, which will allow for primary preimplantation and secondary prevention of NF1.

   Objective: to determine clinical, epidemiological and molecular features of NF1 in the Republic of Bashkortostan.

   Methods. Retrospective analysis of NF1 from the Republic of Bashkortostan, describing NF1 clinical manifestations. Blood was taken to isolate DNA samples.

   Results. NF1 prevalence in the republic was 13.5 per 100,000. The frequency of registration of neurofibromas (58 %), Lisch nodules (1 %), plexiform neurofibromas (7 %), optic nerve gliomas (6 %), and intellectual disability (14 %) is significantly lower than the global average for NF1. The molecular genetic analysis of DNA samples from patients revealed 14 different mutations in NF1 gene in 20 patients from 17 families.

   Conclusions. The frequency of registration of NF1 specific signs in patients from the republic is significantly lower than the world average, which indicates the need for dynamic examination of patients, the whole body MRI, consultations with psychologists and psychiatrists. It is promising to search for mutations in the NF1 gene in all patients.

About the Authors

R. N. Mustafin
Bashkir State Medical University
Russian Federation

450008; 3, Lenina st.; Ufa



E. K. Khusnutdinova
Bashkir State Medical University
Russian Federation

450008; 3, Lenina st.; Ufa



References

1. Gutmann D.H., Ferner R.E., Listernick R.H. et al. Neurofibromatosis type 1. Nat Rev Dis Primers 2017;3:17004.

2. van Minkelen R., van Bever Y., Kromosoeto J.N.R. et al. A clinical and genetic overview of 18 years neurofibromatosis type 1 molecular diagnostics in the Netherlands. Clin Genet. 2014;85(4):318-327.

3. Bata B.M., Hodge D.O., Mohney B.G. Neurofibromatosis type 1: a population-based study. J Pediatr Ophthalmol Strabismus 2019;56(4):243-247.

4. Kang E., Kim Y., Seo G.H. et al. Phenotype categorization of neurofibromatosis type I and correlation to NF1 mutation types. J Hum Genet. 2020;65(2):79-89.

5. Mustafin R.N. Vozmozhnosti diagnostiki i lecheniya neyrofibromatoza 1-go tipa v Rossii. [Prospects for diagnostics and treatment of neurofibromatosis type 1 in Russia]. Sibirskiy onkologicheskiy zhurnal [Siberian journal of oncology]. 2023;22(3):119-124. (In Russ.)

6. Mustafin R.N. Clinical Masks of Neurofibromatosis Type 1. The Russian Archives of Internal Medicine. 2022;12(2):93-103.


Review

For citations:


Mustafin R.N., Khusnutdinova E.K. Study of neurofibromatosis type 1 in the Republic of Bashkortostan – results and prospects. Medical Genetics. 2025;24(8):77-79. (In Russ.) https://doi.org/10.25557/2073-7998.2025.08.77-79

Views: 32


ISSN 2073-7998 (Print)